FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591476489> ?p ?o ?g. }

• W2591476489 endingPage "256" @default.
• W2591476489 startingPage "245" @default.
• W2591476489 abstract "It is evident that standard chemotherapy agents may have an impact on both tumor and host immune system. Paclitaxel (PTX), a very potent anticancer drug from a taxane family, has achieved prominence in clinical oncology for its efficacy against a wide range of tumors including breast cancer. However, significant toxicity, such as myelosuppression, limit the effectiveness of Paclitaxel-based treatment regimens. Immodin (IM) is low molecular dialysate fraction of homogenate made from human leukocytes. It contains a mixture of substances from which so far have been described e.g. Imreg 1 and Imreg 2 formed by the dipeptide tyrosine-glycine and the tripeptide tyrosine-glycine-glycine, respectively. The aim of this study was to explore immunopharmacological activities of IM, using the strongly immunogenic 4T1 mouse breast cancer model, and evaluate its effect on the reactivity and the efficiency of PTX cancer therapy. The results highlight a potentially beneficial role for IM in alleviating PTX-induced toxicity, especially on the nonspecific immunity, during breast cancer therapy. Co-treatment exhibited an antitumor effect including reduced tumor growth, prolonged survival of tumor bearing mice, increased number of monocytes and lymphocytes in peripheral blood. In spleens, IM+PTX therapy elevated proportion of whole lymphocytes in the account of myelo-monocytic cells characteristic with low expression of CD11c+ and bearing Fc receptor (CD16/32) as well as T-lymphocytes, NK cells and dendritic cells. Accumulation of tumor-associated granulocytes in stroma of PTX-treated group and intensive 4T1-necrosis/apoptosis in tumors after co-treatment were also recorded. These findings suggest the possibility of using IM alongside PTX treatment for maintaining the immune system functions and increasing patient survival." @default.
• W2591476489 created "2017-03-03" @default.
• W2591476489 creator A5013434243 @default.
• W2591476489 creator A5015134356 @default.
• W2591476489 creator A5016868823 @default.
• W2591476489 creator A5023958982 @default.
• W2591476489 creator A5033809515 @default.
• W2591476489 creator A5059140373 @default.
• W2591476489 creator A5066851622 @default.
• W2591476489 date "2017-05-01" @default.
• W2591476489 modified "2023-10-14" @default.
• W2591476489 title "Immodin and its immune system supportive role in paclitaxel therapy of 4T1 mouse breast cancer" @default.
• W2591476489 cites W1035770698 @default.
• W2591476489 cites W1045355598 @default.
• W2591476489 cites W1131868295 @default.
• W2591476489 cites W1658946241 @default.
• W2591476489 cites W1923943509 @default.
• W2591476489 cites W1927758176 @default.
• W2591476489 cites W1965371998 @default.
• W2591476489 cites W1982730701 @default.
• W2591476489 cites W1990613023 @default.
• W2591476489 cites W2005251163 @default.
• W2591476489 cites W2008137313 @default.
• W2591476489 cites W2022783631 @default.
• W2591476489 cites W2023354564 @default.
• W2591476489 cites W2024203129 @default.
• W2591476489 cites W2025591320 @default.
• W2591476489 cites W2033680574 @default.
• W2591476489 cites W2033861133 @default.
• W2591476489 cites W2036159305 @default.
• W2591476489 cites W2038402809 @default.
• W2591476489 cites W2039949733 @default.
• W2591476489 cites W2042324432 @default.
• W2591476489 cites W2043017894 @default.
• W2591476489 cites W2069500071 @default.
• W2591476489 cites W2070955248 @default.
• W2591476489 cites W2071601749 @default.
• W2591476489 cites W2071628263 @default.
• W2591476489 cites W2071892399 @default.
• W2591476489 cites W2072212283 @default.
• W2591476489 cites W2079967812 @default.
• W2591476489 cites W2081316389 @default.
• W2591476489 cites W2083353265 @default.
• W2591476489 cites W2083487749 @default.
• W2591476489 cites W2086316696 @default.
• W2591476489 cites W2089918853 @default.
• W2591476489 cites W2091533417 @default.
• W2591476489 cites W2096882227 @default.
• W2591476489 cites W2101477183 @default.
• W2591476489 cites W2101585919 @default.
• W2591476489 cites W2124910438 @default.
• W2591476489 cites W2129476427 @default.
• W2591476489 cites W2139327720 @default.
• W2591476489 cites W2148237316 @default.
• W2591476489 cites W2154667937 @default.
• W2591476489 cites W2154747925 @default.
• W2591476489 cites W2158809810 @default.
• W2591476489 cites W2159490365 @default.
• W2591476489 cites W2176303881 @default.
• W2591476489 cites W227051356 @default.
• W2591476489 cites W2294526468 @default.
• W2591476489 cites W2336492617 @default.
• W2591476489 cites W2521690972 @default.
• W2591476489 cites W2570285573 @default.
• W2591476489 cites W4248626267 @default.
• W2591476489 cites W4254672925 @default.
• W2591476489 cites W4255758041 @default.
• W2591476489 doi "https://doi.org/10.1016/j.biopha.2017.02.034" @default.
• W2591476489 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28235687" @default.
• W2591476489 hasPublicationYear "2017" @default.
• W2591476489 type Work @default.
• W2591476489 sameAs 2591476489 @default.
• W2591476489 citedByCount "11" @default.
• W2591476489 countsByYear W25914764892018 @default.
• W2591476489 countsByYear W25914764892019 @default.
• W2591476489 countsByYear W25914764892020 @default.
• W2591476489 countsByYear W25914764892021 @default.
• W2591476489 countsByYear W25914764892022 @default.
• W2591476489 countsByYear W25914764892023 @default.
• W2591476489 crossrefType "journal-article" @default.
• W2591476489 hasAuthorship W2591476489A5013434243 @default.
• W2591476489 hasAuthorship W2591476489A5015134356 @default.
• W2591476489 hasAuthorship W2591476489A5016868823 @default.
• W2591476489 hasAuthorship W2591476489A5023958982 @default.
• W2591476489 hasAuthorship W2591476489A5033809515 @default.
• W2591476489 hasAuthorship W2591476489A5059140373 @default.
• W2591476489 hasAuthorship W2591476489A5066851622 @default.
• W2591476489 hasConcept C121608353 @default.
• W2591476489 hasConcept C126322002 @default.
• W2591476489 hasConcept C203014093 @default.
• W2591476489 hasConcept C2776694085 @default.
• W2591476489 hasConcept C2777292972 @default.
• W2591476489 hasConcept C2777701055 @default.
• W2591476489 hasConcept C29730261 @default.
• W2591476489 hasConcept C502942594 @default.
• W2591476489 hasConcept C530470458 @default.
• W2591476489 hasConcept C71924100 @default.
• W2591476489 hasConcept C8891405 @default.

• next